CSF leptin levels after exogenous administration of recombinant methionyl human leptin.
Fujioka
K
K
Patane
J
J
Lubina
J
J
Lau
D
D
D000328:Adult; D001812:Blood-Brain Barrier; D002986:Clinical Trials as Topic; D005260:Female; D006801:Humans; D020738:Leptin / Q000008:administration & dosage / Q000031:analogs & derivatives* / Q000097:blood / Q000134:cerebrospinal fluid* / Q000493:pharmacokinetics*; D008297:Male; D008875:Middle Aged; D009765:Obesity / Q000134:cerebrospinal fluid / Q000188:drug therapy / Q000378:metabolism*; D011994:Recombinant Proteins / Q000008:administration & dosage / Q000097:blood / Q000134:cerebrospinal fluid / Q000493:pharmacokinetics
D020738:Leptin; D011994:Recombinant Proteins; C122136:recombinant methionyl human leptin